{
    "title": "Encounter #3 - Outpatient Follow-up",
    "component": "SingleEncounterDocument",
    "props": {
        "encounter": {
            "encounter_no": 3,
            "meta": {
                "visit_type": "Outpatient",
                "date_time": "2024-05-06T09:00:10",
                "provider": {
                    "name": "Dr. P. Stevens",
                    "specialty": "Unknown"
                },
                "ui_risk_color": "yellow"
            },
            "assessment": {
                "impression": "Follow-up regarding normalization of liver function tests and initiation of Methotrexate for rheumatoid arthritis management. Normalization of LFTs with ALT at 35 U/L. Negative workup for chronic liver conditions. Likely transient elevation possibly related to MASLD. Cleared for Methotrexate initiation.",
                "differential": [
                    "Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)",
                    "Acute self-limiting liver episode"
                ]
            },
            "chief_complaint": "Follow-up regarding normalization of liver function tests (LFTs) and potential initiation of Methotrexate for rheumatoid arthritis management.",
            "hpi": "Since the previous review, Sarah reports increased adherence to dietary advice and gentle walking most days, noting a ~1.5 kg weight loss since March. Comprehensive hepatitis workup (viral, autoimmune, metabolic) returned negative. ALT has decreased to 35 U/L, suggesting transient elevation. Patient is considered low-risk for MTX initiation.",
            "medications_prior": [],
            "physical_exam": {
                "general": "Vital Signs: BP 140/88 mmHg (sitting), HR 78 bpm, RR 15/min, Temp 36.6\u00b0C, SpO\u2082 99% on room air.",
                "msk": "",
                "other_systems": "Anthropometrics: Weight 84 kg (BMI 31.2 kg/m\u00b2)."
            },
            "plan": {
                "investigations": {
                    "imaging": [],
                    "labs": [
                        "LFTs every 6 weeks",
                        "FBC every 6 weeks"
                    ]
                },
                "management": {
                    "follow_up": "Follow-up appointment set for early August to review treatment response, adherence to monitoring, and adjust plan. Instructed to begin Methotrexate on 2024-06-03. Emphasized adherence to strict 6-weekly monitoring schedule.",
                    "medications_started": [
                        {
                            "dose": "7.5mg",
                            "frequency": "weekly",
                            "name": "Methotrexate",
                            "route": "Unknown"
                        },
                        {
                            "dose": "5mg",
                            "frequency": "weekly",
                            "name": "Folic acid",
                            "route": "Unknown"
                        }
                    ]
                }
            },
            "reason_for_visit": "Follow-up for liver function tests and rheumatoid arthritis management."
        },
        "patient": {
            "name": "Sarah Miller",
            "sex": "Female",
            "age_at_first_encounter": 43
        },
        "encounterIndex": 3,
        "dataSource": "Electronic Health Record"
    }
}